News Articles

Announcement at kENUP Roundtable: BioNTech Plans mRNA Facility in Africa in Mid-2022 KIGALI, Rwanda -Thursday 28 October 2021

(BUSINESS WIRE) -- BioNTech SE today announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022. This is the next step in BioNTech’s efforts to implement sustainable end-to-end...

CAPRISA and Evotec Launch New Project to Fast-Track New Technology for HIV Prevention -Tuesday 26 October 2021

The Centre for the AIDS Programme of Research in South Africa (CAPRISA) and Evotec establish a new collaboration to develop a broadly neutralizing antibody against HIV to help slow the spread of the virus, especially in Africa. (BUSINESS WIRE)-- Today, at a side meeting during the AU-EU...

Private and Public Sector Join Forces Under the Umbrella of the kENUP Foundation: BioNTech Announces Project to Develop... -Wednesday 28 July 2021  

(BUSINESS WIRE) -- Today, BioNTech SE (“BioNTech”) announced the start of its Malaria project which aims at the development of a safe and highly effective malaria vaccine and the implementation of sustainable vaccine supply solutions on the African continent. The company’s project is...

kENUP Foundation: EIB Launches EUR 50 Million Africa Pharmaceutical Manufacturing Initiative -Friday 18 December 2020  

(BUSINESS WIRE) -- The European Investment Bank today launched the first ever scheme to strengthen local production of Active Pharmaceutical Ingredients in Africa and scale up drug manufacturing essential to improve public health. The EIB’s new EUR 50 million pharmaceutical investment...